Directory profiles that have not opted in. Name, email, and a private contact are not listed. 52 states. Last updated 2026-10-16. Counts are on the catalog.
Page 792. The contact email is not on this page.
- CYTOMICS ANALYTICAL, LLC
NIH R43: Automated Immune Biomarker Fingerprinting for Neurodegenerative Disease Assessment
startup · IN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- VeraMorph Inc.
Form D history: Biotechnology
startup · MA · amount not stated · 2023-04-06
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2023-04-06.
- EVIMERO, LLC
NIH R43: Targeted Immunotherapeutics In Dysbiotic Microbiomes - A Feasibility and Proof-of-Concept Study
startup · AL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PRIVO TECHNOLOGIES, LLC
NIH R44: Support for Registration Enabling Phase 3 Clinical Trial for Nanotechnology-Based Treatment of Carcinoma in Situ of the Oral Cavity (Stage 0 Oral Cancer)
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MAPHABIT, INC.
NIH R44: An assistive-technology based Caregiver Training Program (CTP) to enhance caregiver effectiveness, well-being, and quality of life, which will improve overall care for individuals living with AD/ADRD.
startup · GA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ONCOARENDI THERAPEUTICS, LLC
NIH R43: Myocardin-related transcription factor (MRTF) pathway modulators as a novel, disease-modifying oral medicine for idiopathic pulmonary fibrosis (IPF)
startup · CT · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- IMMUNO TECHNOLOGIES, INC.
NIH R44: Intranasal Vaccine Against Lyme Disease
startup · TN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- CHEMREGEN INC
NIH R43: iPSC-derived human neurons and OUD medications development
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Hillhurst Biopharmaceuticals, Inc.
Form D history: Biotechnology
startup · CA · amount not stated · 2023-09-26
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2023-09-26.
- SYNVENTA, LLC
NIH R43: Etimizol for reversal of Xylazine-fentanyl respiratory depression
startup · AZ · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- KERACEUTICALS, INC.
NIH R41: 1,3-Thioureas as First In Class Mitochondrial Inhibitors to Treat Oral Cancer
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- DYNAMOID, INC.
NIH R44: 10k: A platform for immersive science education
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SERSENSE, INC.
NIH R42: Automated microfluidic device for blood analysis in neonates
startup · MN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NEUROLUX, INC.
NIH R44: Wireless Implantable Mechano-Acoustic Recording Device
startup · IL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PEACEFULLY, INC.
NIH R44: A comprehensive web-based program to help advanced cancer patients plan for end of life
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- RISSANA, LLC
NIH R44: A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
startup · MO · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MAGNETIC INSIGHT, INC.
NIH R44: Development of a prototype clinical theranostic platform combining Magnetic Particle Imaging (MPI) and Magnetic Fluid Hyperthermia (MFH) for the treatment of brain tumors
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- BIOMEDWARE
NIH R44: Geostatistical Software for Non-Parametric Geostatistical Modeling of Uncertainty
startup · MI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- BEHAIVIOR INC.
NIH R44: Modeling Physiology and Behavior of Veterans to Avert Opioid Related Mortality Through Timely Intervention
startup · PA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- GRANITE MEDICAL, LLC
NIH R44: Non-invasively extendable megaprosthesis
startup · NH · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- VALA SCIENCES, INC.
NIH R44: An assay suite featuring hiPSC-derived neurons and support cells, to test toxicants and industrial chemicals for developmental neurotoxic effects
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- GAVIA BIO, LLC
NIH R41: Treating drug-resistant infections of burn wounds with an optimized antimicrobial peptide
startup · MN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- HOPEFUL AGING LLC
NIH R42: Making Connections Thru Music: A Group Music Therapy-Based Intervention for Persons with Dementia
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- LYNNTECH, INC.
NIH R43: Make an OFERR: Optimization for Enhanced RNA Replication
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NEUROLOGIC SOLUTIONS, INC.
NIH R44: EpiScalp: An EEG Analytics Solution to Improve Diagnosis of Epilepsy
startup · VA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ORIDIVUS LLC
NIH R41: Innovative oral regenerative therapy leveraging immunoregenerative mechanisms.
startup · GA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- BIOTEX, INC.
NIH R44: Novel wearable rotating magnetic field therapy device targeting treatment of brain cancers
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- AUGMENTAL TECHNOLOGIES INC.
NIH R43: Development of a novel intra-oral wearable device with an inaudible speech computer interface for users with cervical spinal cord injuries
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SQUARE2 SYSTEMS, INC.
NIH R43: Transforming mental health care via science-based, personalizable and scalable digital therapeutics
startup · NH · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- STORII, INC.
NIH R44: Strengthening Bonds: A Telephone Reminiscence Intervention to Reduce Social Isolation and Improve Mental Health in Rural Older Adults
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- QUA, INC.
NIH R44: Development and Evaluation of the PPAL Bedside Commode for Safe Independent Toileting Transfers
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- EDI THERAPEUTICS LLC
NIH R41: Chimectin as a novel wound biologic for xylazine-induced tissue injury
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- EMPRIME THERAPEUTICS INC
NIH R41: Full Gene Replacement for Hemophilia A Enabled by the StitchR Technology
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NUCB1 HOLDINGS LLC
NIH R43: Development of amyloid conformer-targeting technologies in type 2 diabetes mellitus
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SALIMETRICS, LLC
NIH R43: An At Home Dried Saliva Spot (DSS) Test to Determine Insulin Resistance: A Scalable Tool for Early Detection in Underserved Communities
startup · PA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- BMSEED, LLC
NIH R44: A physiologically relevant pre-clinical drug screening platform for Alzheimer's Disease and Traumatic Brain Injury with integrated stretchable microelectrodes
startup · AZ · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- OUTLIER TECHNOLOGY, LLC
NIH R44: NeuroSync: a data-driven, music-based augmented reality neurorehabilitation platform of games & puzzles to stimulate neuroplasticity and prolong functional independence in Alzheimer's Disease patients
startup · FL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- METANOIA BIO LLC
NIH R41: Targeting PFKFB3 kinase for activation of cell competition and elimination of dysfunctional beta-cells in type-2 diabetes
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MODALITY.AI , INC
NIH R42: A digital tool for monitoring speech decline in ALS
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MEDIA REZ, LLC
NIH R43: Patient-directed technology for non-pharmacologic management of cancer pain
startup · DC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.